𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trials

✍ Scribed by Boneschi, Filippo Martinelli; Rovaris, Marco; Johnson, Kenneth P; Miller, Aaron; Wolinsky, Jerry S; Ladkani, David; Shifroni, Galia; Comi, Giancarlo; Filippi, Massimo

Book ID
119971853
Publisher
SAGE Publications
Year
2003
Tongue
English
Weight
219 KB
Volume
9
Category
Article
ISSN
1352-4585

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

European/Canadian multicenter, double-bl
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis
✍ Giancarlo Comi; Massimo Filippi; Jerry S. Wolinsky πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 698 KB

## Abstract Two prior double‐blind, placebo‐controlled, randomized trials demonstrated that glatiramer acetate (GA) reduces relapse rates in patients with relapsing remitting multiple sclerosis (RRMS). This study was designed to determine the effect, onset, and durability of any effect of GA on dis

Interferon beta-1b is effective in relap
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial
✍ Paty, D. W.; Li, D.K.B. πŸ“‚ Article πŸ“… 1993 πŸ› Lippincott Williams and Wilkins 🌐 English βš– 759 KB

We performed yearly MRI analyses on 327 of the total 372 patients in a multicenter, randomized, double-blind, placebo-controlled trial of interferon beta-1b (IFNB). Clinical results are presented in the preceding companion paper. Baseline MRI characteristics were the same in all treatment groups. Fi